Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Viral genetic heterogeneity in HIV-1-infected individuals is associated with increasing use of HAART and higher viremia.

AIDS (London, England) - 5 May 2000

Ross L, Johnson M, DeMasi R, Liao Q, Graham N, Shaefer M, St Clair M

Abstract excerpt

OBJECTIVE: To assess the correlation between the outgrowth of mutant viruses (viral genetic heterogeneity), highly active antiretroviral therapy (HAART), and plasma HIV-1 RNA in a population-based observational cohort study. DESIGN: The study population consisted of 42 HIV-1-infected individuals receiving at least two nucleotide reverse transcriptase (RT) inhibitors and one or more protease inhibitors at study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Codon
Share to Drug Resistance, Microbial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Reverse Transcriptase Inhibitors

Share to Viremia

Source

Identifiers

PMID: 10839589
DOI: 10.1097/00002030-200005050-00007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Viral genetic heterogeneity in HIV-1-infected individuals is associated with increasing use of HAART and higher viremia.PMID 10839589Read ↗

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.Semantic proximity Read ↗

Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.Semantic proximity Read ↗

Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors.Semantic proximity Read ↗

Initiation of HAART at higher CD4 cell counts is associated with a lower frequency of antiretroviral drug resistance mutations at virologic failure.Semantic proximity Read ↗

Impact of protease polymorphisms and viral fitness on human immunodeficiency virus (HIV) type 1 viremia in untreated HIV-1 infection.Semantic proximity Read ↗

Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults.Semantic proximity Read ↗

Rapid generation of sequence variation during primary HIV-1 infection.Semantic proximity Read ↗

HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability.Semantic proximity Read ↗

Characterization of the viral population during primary HIV-1 infection.Semantic proximity Read ↗

Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.Semantic proximity Read ↗

Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses.Semantic proximity Read ↗

Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.